Aligos Therapeutics Inc (ALGS)
0.685
+0.03
(+4.58%)
USD |
NASDAQ |
May 17, 16:00
0.685
0.00 (0.00%)
Pre-Market: 20:00
Aligos Therapeutics 1 Year Total Returns (Daily): -42.14% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -42.14% |
May 16, 2024 | -43.04% |
May 15, 2024 | -47.76% |
May 14, 2024 | -36.56% |
May 13, 2024 | -37.19% |
May 10, 2024 | -39.14% |
May 09, 2024 | -36.87% |
May 08, 2024 | -36.33% |
May 07, 2024 | -36.29% |
May 06, 2024 | -34.68% |
May 03, 2024 | -38.16% |
May 02, 2024 | -30.08% |
May 01, 2024 | -39.37% |
April 30, 2024 | -34.05% |
April 29, 2024 | -36.74% |
April 26, 2024 | -24.44% |
April 25, 2024 | -20.58% |
April 24, 2024 | -17.51% |
April 23, 2024 | -18.46% |
April 22, 2024 | -20.69% |
April 19, 2024 | -24.17% |
April 18, 2024 | -16.56% |
April 17, 2024 | -14.08% |
April 16, 2024 | -10.21% |
April 15, 2024 | -3.79% |
Date | Value |
---|---|
April 12, 2024 | 9.85% |
April 11, 2024 | 17.84% |
April 10, 2024 | 16.64% |
April 09, 2024 | 17.78% |
April 08, 2024 | 18.89% |
April 05, 2024 | 14.66% |
April 04, 2024 | 7.13% |
April 03, 2024 | 13.23% |
April 02, 2024 | 11.90% |
April 01, 2024 | 8.86% |
March 28, 2024 | -11.71% |
March 27, 2024 | -15.60% |
March 26, 2024 | -9.73% |
March 25, 2024 | -16.93% |
March 22, 2024 | -14.66% |
March 21, 2024 | -20.83% |
March 20, 2024 | -24.37% |
March 19, 2024 | -29.42% |
March 18, 2024 | -30.30% |
March 15, 2024 | -31.23% |
March 14, 2024 | -36.05% |
March 13, 2024 | -33.08% |
March 12, 2024 | -34.09% |
March 11, 2024 | -33.33% |
March 08, 2024 | -42.06% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.16%
Minimum
May 06 2022
18.89%
Maximum
Apr 08 2024
-54.54%
Average
-46.32%
Median
1 Year Total Returns (Daily) Benchmarks
Mirum Pharmaceuticals Inc | -8.02% |
CEL-SCI Corp | -52.96% |
AIM ImmunoTech Inc | -19.40% |
IGC Pharma Inc | 69.70% |
NovaBay Pharmaceuticals Inc | -83.53% |